An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Interventions
DRUG

Azithromycin

Trial Locations (6)

10468

Bronx Veterans Affairs Med Ctr, The Bronx

13210

SUNY / Health Sciences Ctr at Syracuse, Syracuse

43210

Ohio State Univ Hosp, Columbus

78236

United States Air Force Med Ctr, Lackland Air Force Base

78284

Audie L Murphy Veterans Administration Hosp, San Antonio

02215

Beth Israel Hosp, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00002090 - An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) | Biotech Hunter | Biotech Hunter